Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 29,600 | 27,920 | 7,288 | N/A |
| Marketable Securities | 4,040 | 8,750 | 9,207 | N/A |
| Other current assets | 180 | 450 | 397 | 0 |
| TOTAL | $33,820 | $37,120 | $16,892 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,410 | 890 | 632 | N/A |
| Other Non-Current Assets | 1,850 | 440 | 769 | 0 |
| TOTAL | $4,260 | $1,330 | $1,401 | $N/A |
| Total Assets | $38,090 | $38,460 | $18,293 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 760 | 710 | 322 | 0 |
| Accrued Expenses | 610 | 410 | 353 | N/A |
| Other current liabilities | 60 | 750 | 471 | N/A |
| TOTAL | $1,810 | $2,070 | $1,464 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 740 | 0 | 58 | N/A |
| TOTAL | $740 | $N/A | $62 | $N/A |
| Total Liabilities | $2,550 | $2,070 | $1,526 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | 1 | N/A |
| Retained earnings | -44,250 | -33,710 | -26,152 | N/A |
| Other shareholders' equity | -1 | -11 | 0 | 0 |
| TOTAL | $35,540 | $36,380 | $16,767 | $N/A |
| Total Liabilities And Equity | $38,090 | $38,450 | $18,293 | $0 |